A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer (Q33360152)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer |
scientific article |
Statements
1 reference
A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer (English)
1 reference
1 reference
Ursula Matulonis
1 reference
Michael V Seiden
1 reference
Allan Astrow
1 reference
Susanna Campos
1 reference
Maria Roche
1 reference
Julia Sivret
1 reference
Jason Rusk
1 reference
Emma Barrett
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference